"Founded in 1989 under the name Tyler Hematology-Oncology, our team of highly credentialed & experienced oncologists has earned a reputation as an authority on cancer care in East Texas. Today, HOPE Cancer Center of East Texas — reflects our focus, hope, as well as our longstanding and ongoing commitment to providing the highest-quality care for people with cancer and blood disorders. To help you have hope in the fight against cancer, we bring together the complete array of modern cancer care with a powerful sense of compassion and dedication to your unique needs. From highly trained, highly skilled doctors, nurses & staff to state-of-the-art methods, unsurpassed accessibility and individualized care, we offer the top-quality care you need."

During the past decade, Tyler Cancer Center conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 48 clinical trials were completed, i.e. on average, 154.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 18 clinical trials were completed. i.e. 163.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tyler Cancer Center" #1 sponsor was "Novartis Pharmaceuticals" with 11 trials, followed by "US Oncology Research" with 11 trials sponsored, "Eli Lilly and Company" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 7 trials sponsored and "National Cancer Institute (NCI)" with 7 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tyler Cancer Center" #1 collaborator was "NRG Oncology" with 12 trials as a collaborator, "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Sanofi" with 4 trials as a collaborator, "US Oncology Research" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Tyler Cancer Center" are "Breast Cancer" (14 trials), "Prostate Cancer" (9 trials), "Lung Cancer" (8 trials), "Metastatic Breast Cancer" (6 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Tyler Cancer Center" in a lesser frequency.

Most popular intervention types in "Tyler Cancer Center" are "Drug" (118 trials), "Other" (16 trials), "Biological" (14 trials), "Radiation" (13 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Carboplatin" (11 trials), "Docetaxel" (9 trials), "Laboratory Biomarker Analysis" (9 trials) and "Paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Tyler Cancer Center" are 101 trials for "All" genders, 18 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Tyler Cancer Center". undefined are not yet recruiting, 9 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 82 completed trials in Tyler Cancer Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Tyler Cancer Center, 22 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Tyler Cancer Center has several departments that took part in Clinical trials: "Tyler Hematology-Oncology, PA" - 12 trials